Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

Phase 2

Completed

• Conditions: Cocaine-Related Disorders; Substance-Related Disorders
• Interventions: Drug: Placebo; Drug: D-Amphetamine; Drug: Dextroamphetamine

• Registration Number: NCT00000304
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.

Detailed Description

Not available

Study Timeline

• Study Start: 1997-08
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Primary Completion: 2001-08
• Study Completion: 2001-08
• Status Verified: 2016-10
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
3	Placebo	placebo
2	D-Amphetamine	30/60 mg d-amphetamine
1	Dextroamphetamine	15/30 mg d-amphetamine

Primary Outcome Measures

Name	Time	Method
verifiable cocaine abstinence	16 weeks of study

Trial Locations

Locations (1)

University of Texas Health Science Center; 🇺🇸 Houston, Texas, United States